Novartis (Bangladesh) Limited operates as a subsidiary of Novartis AG, a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history of more than 250 years.
The company provides healthcare solutions specializing in research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Novartis operates businesses with global scale and strong customer ties, focusing on innovative patented medicines, generics and eye care devices.
Supported by a strong corporate governance framework based on the most stringent compliance standards, the company operates with the highest principles of uncompromising integrity. Novartis (Bangladesh) Limited exports its products to more than 50 countries in Europe, Asia, Africa and America. As the country’s leading pharmaceutical exporters, Novartis (Bangladesh) Limited received the National Export Trophy (GOLD) three times.
Journey of NBL
1973: Registration at joint stock company as Ciba Geigy (Bangladesh) Limited.
1979: Joint venture agreement between Bangladesh Chemical Industries Corporation (BCIC) and Ciba Geigy.
1986: Introduction of Ophthalmic products in the Bangladeshi market.
1989: Inauguration of the Novartis Plant, a state of the art pharmaceutical manufacturing plant in Bangladesh.
1995: For the first time exported our manufactured products to Vietnam.
1997: Novartis (Bangladesh) Limited took birth from the merger of Ciba Geigy and Sandoz in Bangladesh.
1999: sold off Crop Protection business to Syngenta.
2000: awarded the EU GMP certification as the first pharmaceutical company in Bangladesh.
2003: Sandoz re-entered Bangladeshi market with generic products.
2008: awarded the National Gold Trophy - Gold for the Years 2002-2003 and 2003-2004
Contribution to Nation
National Treasury: Novartis contributed BDT 3,529,605,835 in last 5 years in the form of VAT, corporate tax and withholding tax in addition to excise and customs duty.